Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 June 2025 | Story Leonie Bolleurs | Photo Supplied
SASUF
SASUF student members join Kovsie ACT in maintaining food garden beds on the Bloemfontein Campus.

There is something powerful about getting your hands in the soil, even more so when it is to help someone else. That is exactly what the group of South Africa–Sweden University Forum (SASUF) students did at the end of May, marking World Hunger Day by joining forces with Kovsie ACT to maintain and prepare food garden beds on the University of the Free State (UFS) Bloemfontein Campus.

The SASUF student team is helping with the upkeep of 40 vegetable beds in the food tunnels near Welwitschia Residence. These beds were established to supply fresh produce to students in need – a small effort with a big purpose.

Simba Matema, Research Assistant from the Office for International Affairs and SASUF Student Network National Coordinator, says this project is about more than planting vegetables. “We want to make sure that students who are struggling financially can benefit. But we also want to learn, to grow skills in agriculture and sustainability,” he explains.

 

A learning experience with real impact

Second-year student Lesego Moeleso says being involved in the garden is “a refreshing change of scenery” and a great way to “interact with students from different fields of study”. He adds: “We all want to help our fellow students who don’t have enough food.” 

Third-year UFS student Njabulo Sibeko agrees. “It’s a unique mix of academic enrichment, personal growth, and community engagement,” he says. “Even if the impact is small, it goes a long way. This project gives us a chance for hands-on learning and skills development, environmental sustainability and awareness, as well as social connections.”

Sibeko believes the garden also works as a “live experiment for environmental education”, teaching about “composting, water conservation, and organic farming”. He says, “Different vegetables have different nutrition, and if we can hold small workshops as to why we need to eat specific vegetables during different seasons, it will help teach us about the value they have for our body.”

Final-year Law student Shemsa Nzeyimana says her favourite part of being involved is “seeing the impact of our efforts” and “watching the garden grow and flourish”. “I love being part of a team that shares a common vision for creating positive change through sustainable practices,” she says. “And the fact that I get to be out of my comfort zone while building my social skills.”

 

Towards a sustainable solution

Nzeyimana hopes the garden “will become a hub for community engagement”, connecting students, staff, and locals while promoting sustainable food systems. “The garden directly addresses food security while also serving as a hands-on learning space for nutritional education and sustainable agriculture,” she adds. “By promoting sustainable gardening practices, the garden raises environmental awareness and encourages the campus community to think critically about food systems and their impact.”

At the UFS, where 59% of students report going hungry and 60% skip meals for financial reasons, the need is undeniable. Matema says by “giving students a role in the solution”, the stigma around food aid is reduced. “It becomes a shared project, not a handout.”

As Nzeyimana sums it up: “This garden can become a space for learning, connection, and hope – a place where change grows from the ground up.”

Besides Kovsie ACT, the initiative includes partners such as the Institute for Groundwater Studies, University Estates, the UFS Food Environment Office, and residences. External partners such as Tiger Brands, Sakata Seeds, and Kwaggafontein Nursery also support the project.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept